期刊文献+

RP-HPLC法检测阿齐沙坦有关物质的方法改进

Improvement of Determination on the Related Substances in Azilsartan by RP-HPLC
下载PDF
导出
摘要 目的建立一种新的阿齐沙坦有关物质检测方法。方法以YMC Triart C 18(4.6×250 mm,5μm)为色谱柱;以0.05 mol·L^(-1)乙酸铵缓冲液(氨水调节pH至9.0)为流动相A,甲醇为流动相B,线性梯度洗脱;流速0.8 mL·min^(-1);检测波长251 nm。结果阿齐沙坦与各杂质分离良好,各杂质和阿齐沙坦质量浓度0.1~1.0μg·mL^(-1)范围内,浓度与峰面积呈良好的线性关系,相关系数0.9990~1.0000;1、2、3、4和5检测限分别为0.0476、0.0570、0.0532、0.0588和0.0556μg·mL^(-1),平均回收率分别为96.66%、109.94%、102.18%、100.62%和100.26%,RSD分别为5.53%、6.14%、1.45%、3.0%和3.48%(n=9)。结论本法专属、可靠,可用于阿齐沙坦原料药有关物质的测定。 OBJECTIVE To establish a new method for the determination of related substances in azilsartan by RP-HPLC.METHODS The determination was performed on a YMC Triart C 18 column(4.6×250 mm,5μm)and the mobile phase A consisted of 0.5 mol·L^(-1) ammonium acetate buffer solution(adjust pH to 9.0 with ammonium hydroxide),the mobile phase B consisted of methanol.Linear gradient elution.The detection wavelength and flow rate was 251 nm and 0.8 mL·min^(-1) respectively.RESULTS An excellent separation was achieved for related substances in azilsartan under the above chromatographic conditions.The calibration cures for azilsartan and its related substances revealed good linearities over the ranges of 0.1-1.0μg·mL^(-1),the correlation coefficient was 0.9990-1.0000.The LOD of 1,2,3,4,5 was 0.0476μg·mL^(-1),0.0570μg·mL^(-1),0.0532μg·mL^(-1),0.0588μg·mL^(-1),0.0556μg·mL^(-1),average recovery was 99.66%,109.94%,102.18%,100.62%,100.26%respectively and the RSD was 5.53%,6.14%,1.45%,3.0%,3.48%(n=9).CONCLUSION The method was accurate and sensitive for separation and detection related substances in azilsartan.
作者 张丽 刘发贵 杨丹丹 李敏 刘思光 张贵民 ZHANG Li;LIU Fa-gui;YANG Dan-dan;LI Min;LUI Si-guang;ZHANG Gui-min(National Engineering Research Center of Chiral Drugs,Lunan Pharmaceutical Group,Linyi 273400,China)
出处 《海峡药学》 2023年第5期60-62,共3页 Strait Pharmaceutical Journal
关键词 RP-HPLC 有关物质 阿齐沙坦 RP-HPLC Related substances Azilsartan
  • 相关文献

参考文献9

二级参考文献38

  • 1谢沐风.药物溶液稳定性试验的验证方法与重要性[J].药物分析杂志,2005,25(1):107-109. 被引量:27
  • 2谢沐风.如何建立高效液相色谱法测定有关物质的方法[J].中国医药工业杂志,2007,38(1):45-48. 被引量:61
  • 3周海钧译.药品注册的国际技术要求(质量部分)[M].北京:人民卫生出版社,2000.
  • 4FDA.Office of generic drugs[EB/OL].[2006-01-31].http://www.fda.gov/cder/ogd
  • 5Rakugi H,Kario K,Enya K,et al.Effect of azilsartan versus candesartan on nocturnal blood pressure variation in Japanese patients with essential hypertension[J].Blood Press,2013,22(S1): 22.
  • 6Lam S.Azilsartan: a newly approved angiotensin Ⅱ receptor blocker[J].Cardiol Rev,2011,19(6): 300.
  • 7Ebeid WM,Elkady EF,El-Zaher AA,et al.Spectrophotometric and spectrofluorimetric studies on azilsartan medoxomil and chlorthalidone to be utilized in their determination in pharmaceuticals[J].Anal Chem Insights,2014,9:33.
  • 8Vekariya PP,Joshi HS.Development and validation of RP-HPLC method for azilsartan medoxomil potassium quantitation in human plasma by solid phase extraction procedure[J].ISRN Spectrosc, 2013; doi:10.1155/2013/572170.
  • 9阎峰,关瑾,陈星,石爽,傅业荣,刘晓霞.高效毛细管电泳法测定乳氟禾草灵的含量[J].农药,2010,49(9):662-663. 被引量:3
  • 10束蓓艳,吴雪松,岑均达.阿奇沙坦的合成[J].中国医药工业杂志,2010,41(12):881-883. 被引量:10

共引文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部